Zurcher Kantonalbank Zurich Cantonalbank Boosts Stake in Amrize Ltd $AMRZ

20 Apr 2026, 08:02 by Amy Steele · The Cerbat Gem

Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Amrize Ltd (NYSE:AMRZ – Free Report) by 1.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,674,921 shares of the company’s stock after buying an additional 156,903 shares during the quarter. Amrize comprises about 1.1% of Zurcher Kantonalbank Zurich Cantonalbank’s investment portfolio, making the stock its 14th biggest position. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Amrize were worth $532,076,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently made changes to their positions in AMRZ. Geode Capital Management LLC purchased a new stake in shares of Amrize in the second quarter valued at $265,000. M&T Bank Corp acquired a new stake in shares of Amrize during the second quarter valued at $205,000. Arrowstreet Capital Limited Partnership purchased a new stake in Amrize during the 2nd quarter worth about $3,870,000. Gabelli Funds LLC purchased a new stake in Amrize during the 2nd quarter worth about $1,083,000. Finally, AXA S.A. acquired a new position in Amrize in the 2nd quarter valued at about $1,065,000.

Amrize Trading Up 0.2%

Shares of AMRZ stock opened at $57.80 on Monday. The firm’s 50-day simple moving average is $58.41 and its 200-day simple moving average is $54.41. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.64 and a quick ratio of 1.10. Amrize Ltd has a 1-year low of $44.12 and a 1-year high of $65.94. The firm has a market cap of $31.97 billion and a P/E ratio of 23.50.

Amrize (NYSE:AMRZ – Get Free Report) last released its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.03. The company had revenue of $2.84 billion during the quarter, compared to analysts’ expectations of $2.95 billion. The business’s revenue for the quarter was down .4% compared to the same quarter last year.

Amrize Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Monday, May 4th. Stockholders of record on Monday, April 27th will be paid a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, April 24th.

Insider Activity at Amrize

In other news, CEO Jan Philipp Jenisch acquired 60,000 shares of the company’s stock in a transaction dated Friday, March 6th. The stock was acquired at an average cost of $58.05 per share, for a total transaction of $3,483,000.00. Following the acquisition, the chief executive officer directly owned 1,703,582 shares in the company, valued at approximately $98,892,935.10. This represents a 3.65% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, CTO Roald Brouwer bought 2,000 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The stock was purchased at an average cost of $54.88 per share, for a total transaction of $109,760.00. Following the completion of the transaction, the chief technology officer directly owned 18,257 shares in the company, valued at approximately $1,001,944.16. This trade represents a 12.30% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders bought 77,834 shares of company stock worth $4,511,344. 0.54% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have issued reports on AMRZ. Wells Fargo & Company reduced their target price on shares of Amrize from $66.00 to $65.00 and set an “overweight” rating on the stock in a report on Wednesday. Oppenheimer reissued an “outperform” rating and issued a $70.00 price objective (up from $64.00) on shares of Amrize in a research report on Thursday, February 19th. Wall Street Zen raised shares of Amrize from a “sell” rating to a “hold” rating in a research note on Sunday, March 1st. Bank of America set a $58.00 target price on shares of Amrize in a research note on Monday, January 12th. Finally, Citigroup boosted their price target on Amrize from $63.00 to $67.00 and gave the company a “buy” rating in a report on Thursday, January 8th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $64.07.

Get Our Latest Analysis on AMRZ

Amrize Profile

(Free Report)